Adverse Drug Reaction News Bulletins
ADR News Bulletin 2018 May (Volume 20 Number 1)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 May 2018
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Gadolinium-based contrast agents and risk of gadolinium brain deposits
AE Case in Focus: Test Yourself
Risk of severe cutaneous adverse reactions with recombinant human erythropoeitins
Update on canagliflozin and risk of lower limb amputation
Caution on the use of lysozyme-containing products in patients with known egg allergy
Answers to AE Case in Focus: Test Yourself
List of Dear Healthcare Professional Letters
Non-steroidal anti-inflammatory drugs and cardiovascular risk - An update and reminder
Analysis of adverse event reports for year 2017 (bulletin insert)
Click on the link below to download the issue in pdf:
ADR_News_May2018_Vol20_No1 [PDF, 1139 KB]
Analysis of AE reports for Year 2017_May2018_Vol 20_No1 [PDF, 714 KB]